Multiple Sclerosis, Relapsing-Remitting
"Multiple Sclerosis, Relapsing-Remitting" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914)
MeSH Number(s)
C10.114.375.500.600
C10.314.350.500.600
C20.111.258.250.500.600
Concept/Terms
Multiple Sclerosis, Relapsing-Remitting- Multiple Sclerosis, Relapsing-Remitting
- Multiple Sclerosis, Relapsing Remitting
- Remitting-Relapsing Multiple Sclerosis
- Multiple Sclerosis, Remitting-Relapsing
- Remitting Relapsing Multiple Sclerosis
- Relapsing-Remitting Multiple Sclerosis
- Relapsing Remitting Multiple Sclerosis
Below are MeSH descriptors whose meaning is more general than "Multiple Sclerosis, Relapsing-Remitting".
Below are MeSH descriptors whose meaning is more specific than "Multiple Sclerosis, Relapsing-Remitting".
This graph shows the total number of publications written about "Multiple Sclerosis, Relapsing-Remitting" by people in Harvard Catalyst Profiles by year, and whether "Multiple Sclerosis, Relapsing-Remitting" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 2 | 1 | 3 |
| 2000 | 5 | 2 | 7 |
| 2001 | 4 | 0 | 4 |
| 2002 | 5 | 1 | 6 |
| 2003 | 6 | 2 | 8 |
| 2004 | 7 | 0 | 7 |
| 2005 | 6 | 2 | 8 |
| 2006 | 4 | 0 | 4 |
| 2007 | 8 | 1 | 9 |
| 2008 | 10 | 1 | 11 |
| 2009 | 12 | 2 | 14 |
| 2010 | 2 | 0 | 2 |
| 2011 | 10 | 1 | 11 |
| 2012 | 14 | 0 | 14 |
| 2013 | 8 | 3 | 11 |
| 2014 | 5 | 2 | 7 |
| 2015 | 17 | 3 | 20 |
| 2016 | 23 | 0 | 23 |
| 2017 | 10 | 0 | 10 |
| 2018 | 13 | 1 | 14 |
| 2019 | 15 | 2 | 17 |
| 2020 | 14 | 0 | 14 |
| 2021 | 16 | 0 | 16 |
| 2022 | 11 | 0 | 11 |
| 2023 | 2 | 0 | 2 |
Below are the most recent publications written about "Multiple Sclerosis, Relapsing-Remitting" by people in Profiles.
-
Family planning considerations in people with multiple sclerosis. Lancet Neurol. 2023 Apr; 22(4):350-366.
-
Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial. Mult Scler. 2023 Mar; 29(3):385-394.
-
External validation of a clinical prediction model in multiple sclerosis. Mult Scler. 2023 02; 29(2):261-269.
-
Exploring the effect of glatiramer acetate on cerebral gray matter atrophy in multiple sclerosis. J Neurol Sci. 2023 01 15; 444:120501.
-
Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2022 12; 93(12):1330-1337.
-
How patients with multiple sclerosis acquire disability. Brain. 2022 09 14; 145(9):3147-3161.
-
Evaluation of white matter microstructure in pediatric onset multiple sclerosis with diffusion compartment imaging. J Neuroimaging. 2022 11; 32(6):1098-1108.
-
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis. Neurology. 2022 10 25; 99(17):e1926-e1944.
-
A real world multi center study on efficacy and safety of natalizumab in Indian patients with multiple sclerosis. Mult Scler Relat Disord. 2022 Oct; 66:104059.
-
Disease modifying therapy management of multiple sclerosis after stem cell therapies: A retrospective case series. Mult Scler Relat Disord. 2022 Jul; 63:103861.